Prostate cancer Board decisions

The Board has withdrawn the Veteran's appeals regarding his service-connected surgical scar, tenderness of the surgical scar as secondary to prostate cancer, and erectile dysfunction. The appeal for a compensable disability rating for residuals of prostate cancer is remanded due to outstanding medical records and the need for a more contemporaneous VA examination.

The Board has granted service connection for prostate cancer on the basis of presumed exposure to herbicide agents during service. The issue of entitlement to a total disability rating due to individual unemployability (TDIU) is remanded.

The Board denied a higher rating for residuals of prostate cancer, finding that the Veteran's voiding dysfunction did not warrant a rating higher than 40 percent.

The Veteran's prostate cancer and CLL are presumed related to his herbicide exposure. The Veteran's basal cell carcinoma on the face, head, and neck is granted service connection under presumptive criteria, but a rating in excess of 30 percent from March 31, 2014 is denied.

The Board has granted service connection for hypertension, hypertrophic cardiomyopathy, diabetes mellitus type II, and prostate cancer secondary to the Veteran's service-connected orthopedic disabilities on a basis of aggravation with obesity as an intermediate step.

The Board has decided to remand the case due to inadequate medical opinion and failure to comply with previous remands. The Veteran's prostate cancer is related to his service, specifically exposure to burn pits during his Gulf War service.

The Veteran's residuals of prostate cancer are currently rated at 40 percent, and the Board has determined that this rating is not appropriate for an evaluation in excess of 40 percent.

The Board denied the Veteran's claims of service connection for bladder cancer, ischemic heart disease (IHD), and prostate cancer. The evidence submitted since the June 2016 decision did not provide new or material information to support these claims.

The Veteran's prostate cancer and related residuals are rated at 100% from September 10, 2014 to April 27, 2015. He is also granted SMC based on housebound status for this period.

The Board denied service connection for diabetes mellitus and prostate cancer as a result of herbicide exposure due to the lack of evidence supporting in-service exposure.,Both conditions were found not related to service, with no presumption of exposure applied.

The Board denied service connection for the claimed conditions as due to herbicide exposure, finding that there was no evidence of such exposure during active duty.

The Veteran's appeal for increased ratings for prostate cancer and depressive disorder was denied. The Veteran also received a grant of TDIU.

The Veteran's prostate cancer status post brachytherapy is remanded for further evaluation due to a challenge to the competency of the February 2016 VA examiner.

The Board has decided to remand the case due to inadequate reasons or bases for its denial decision, including VA's failure to notify the appellant of a private physician's medical records. The matter is now being returned to the Board for further consideration.

Service connection is granted for residuals of prostate cancer and heart condition (including an old inferior myocardial infarction).,The Veteran's kidney cancer claim is remanded as additional medical records are needed to determine the relationship between his service-connected conditions and his current health issues.

The Board has dismissed the Veteran's appeals for service connection on all issues related to his claimed conditions, as the appellant withdrew these claims through their authorized representative.

The Board has decided that additional development is needed to verify the Veteran's claimed exposure to herbicides while aboard the USS Raleigh, and thus the cases are being remanded for further action.

The Veteran's service connection for prostate cancer is granted due to presumed exposure to herbicide agents during service in Thailand. The issue of an initial compensable rating prior to May 16, 2018, and an increased rating thereafter for bilateral hearing loss is remanded.

The Veteran's prostate cancer is presumed to be causally related to his in-service herbicide exposure at Ubon RTAFB and Nakhon Phanom RTAFB in Thailand, and the claim for service connection is granted.

The Veteran's prostate cancer and bilateral hearing loss ratings are being remanded for additional development, including a new examination to assess the current severity of his service-connected disabilities.